 1 Agents affecting nervous system and sensory organs
|
 11 Agents affecting central nervous system
|
12 Agents affecting peripheral nervous system
|
121 Local anesthetics
|
1211 Aminobenzoate alkamine esters
|
 1212 Aminobenzoate alkyl esters
|
1213 Dibucaines
|
1214 Xylidines
|
D00358 Lidocaine (JP18/USP/INN)
D02086 Lidocaine hydrochloride (JAN/USP)
D08127 Lidocaine hydrochloride monohydrate
D01450 Bupivacaine hydrochloride (USP); Bupivacaine hydrochloride hydrate (JP18)
D00738 Mepivacaine hydrochloride (JP18/USP)
D04048 Ropivacaine hydrochloride (USP); Ropivacaine hydrochloride hydrate (JAN)
D01287 Levobupivacaine hydrochloride (JAN/USAN)
D04052 Epinephrine and lidocaine hydrochloride
|
1215 Alkaloids
|
1219 Others
|
D01152 Oxethazaine (JP18/USAN); Oxetacaine (INN)
D02740 Lidocaine and prilocaine
|
122 Skeletal muscle relaxants
|
1221 Mephenesins
|
1222 Chlorzoxazons
|
1223 Synthetic curares
|
1224 Cholines
|
D02275 Suxamethonium chloride hydrate (JP18)
|
1225 Carbamates
|
D00402 Methocarbamol (JAN/USP/INN)
D00770 Chlorphenesin carbamate (JP18/USAN)
|
1226 Alkaloids
|
1229 Others
|
D00765 Rocuronium bromide (JAN/USP/INN)
D00783 Botulinum toxin type A (JAN)
D02064 Pridinol mesilate (JAN)
D02274 Dantrolene sodium (USP); Dantrolene sodium hydrate (JP18)
D10012 Incobotulinumtoxin A (JAN/USAN)
|
123 Autonomic nervous system agents
|
124 Antispasmodics
|
125 Diaphoretics, anhidrotics
|
129 Miscellaneous
|
13 Agents affecting sensory organs
|
19 Other agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan